Thursday October 4th

 

Thursday October 4th, Palais de l’Europe, Menton

Presentations are available for viewing in PDF format but should not be used without authors’ permission

07.00 – 08.30

Poster mounting and attendee registration

08.00 – 08.30: Opening

B. Coiffier, M. Federico, M. Meignan , A. Gallamini , C. Haioun, A. Polliack

08.30 – 11.30: International Workshop on PET in lymphoma staging and restaging

Chairmen: B. Cheson, A. Lister, R. Fisher
S. Barrington and Nuclear Medicine task force

(including 15 min coffee break)

      • New recommendations – summary of the workshop (S. Barrington) 
      • When to use PET-CT (L. Kostakoglu) 
      • Imaging of bone marrow (M. Hutchings) 
      • Assessment of bulk (L. Schwartz) 
      • Mid treatment assessment (G. Mikhaeel) 
      • Significance of residual masses (G. Mikhaeel) 
      • Quantitation 1 – standardisation (S. Müller) 
      • Quantitation 2 – use of the δSUV (M. Meignan) 
      • Conclusion : proposed new response criteria (G. Mikhaeel) 

11.30 – 12.00: Economic perspectives of PET in lymphoma

Chairman: E. Zucca
J.J. Cerci 
Session sponsored by a restricted grant from Amgen

12.00 – 14.00: Poster viewing and Lunch

Book of abstracts 

14.00 – 15.30: Afternoon controversies

Is PET useful in non-Hodgkin lymphoma other than DLBCL

Moderators: S. Luminari, F. Bodéré, M. Meignan, B. Coiffier

14.00 – 14.30: Follicular lymphoma

The role of PET/CT in the management of Follicular lymphoma: predictive and prognostic roles
J. Trotman, M. Federico
 

14.30 – 15.30: Other lymphoma subtypes

Potential applications of PET/CT in MALT and PMBCL: L. Ceriani, G. Paone, E. Zucca 

Potential applications of PET/CT in mantle cell lymphoma: S. le Gouill, C. Bodet-Millin 

Potential applications of PET/CT in T-cell lymphoma: C. Moskowitz, H. Schöder 

15.30 – 15.45: Coffee break

15.45 – 16.15

SNMMI and scientific and educational cooperation: F. Fahey

EANM policy and Menton meeting: A. Chiti

16.15 – 17.45; Interim PET in early-stage Hodgkin lymphoma

Moderators: O. Casasnovas, S. Bardet

Round table: intergroup trials

J. Radford, M. André, A. Engert, M. Federico, M. Hutchings, M. Meignan, A. Versari

      • German Hodgkin Study Group (C. Kobe) 
      • RAPID trial (J. Radford)

PET in H10 trial: an interim analysis

      • H10 trial (C. Fortpied)
      • H10 trial (M. André)

20.00: Gala dinner